Table of Contents 1 Microbiome Therapeutics Market Overview 1.1 Product Overview and Scope of Microbiome Therapeutics 1.2 Classification of Microbiome Therapeutics by Type 1.2.1 Global Microbiome Therapeutics Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Global Microbiome Therapeutics Revenue Market Share by Type in 2019 1.2.3 Upper GIT 1.2.4 Lower GIT 1.3 Global Microbiome Therapeutics Market by Application 1.3.1 Overview: Global Microbiome Therapeutics Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Inflammatory Bowel Disease (IBD) 1.3.3 Orphan Drug 1.3.4 Immuno-oncology 1.3.5 Others 1.4 Global Microbiome Therapeutics Market by Regions 1.4.1 Global Microbiome Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025 1.4.2 Global Market Size of Microbiome Therapeutics (2015-2025) 1.4.3 North America (USA, Canada and Mexico) Microbiome Therapeutics Status and Prospect (2015-2025) 1.4.4 Europe (Germany, France, UK, Russia and Italy) Microbiome Therapeutics Status and Prospect (2015-2025) 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Microbiome Therapeutics Status and Prospect (2015-2025) 1.4.6 South America (Brazil, Argentina, Colombia) Microbiome Therapeutics Status and Prospect (2015-2025) 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Microbiome Therapeutics Status and Prospect (2015-2025) 2 Company Profiles 2.1 Seres Therapeutics 2.1.1 Seres Therapeutics Details 2.1.2 Seres Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 Seres Therapeutics SWOT Analysis 2.1.4 Seres Therapeutics Product and Services 2.1.5 Seres Therapeutics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.2 4D Pharma 2.2.1 4D Pharma Details 2.2.2 4D Pharma Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 4D Pharma SWOT Analysis 2.2.4 4D Pharma Product and Services 2.2.5 4D Pharma Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.3 Interxon 2.3.1 Interxon Details 2.3.2 Interxon Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Interxon SWOT Analysis 2.3.4 Interxon Product and Services 2.3.5 Interxon Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.4 Assembly Biosciences 2.4.1 Assembly Biosciences Details 2.4.2 Assembly Biosciences Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 Assembly Biosciences SWOT Analysis 2.4.4 Assembly Biosciences Product and Services 2.4.5 Assembly Biosciences Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.5 Enterome BioScience 2.5.1 Enterome BioScience Details 2.5.2 Enterome BioScience Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 Enterome BioScience SWOT Analysis 2.5.4 Enterome BioScience Product and Services 2.5.5 Enterome BioScience Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.6 Synthetic Biologics 2.6.1 Synthetic Biologics Details 2.6.2 Synthetic Biologics Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 Synthetic Biologics SWOT Analysis 2.6.4 Synthetic Biologics Product and Services 2.6.5 Synthetic Biologics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.7 AOBiome 2.7.1 AOBiome Details 2.7.2 AOBiome Major Business and Total Revenue (Financial Highlights) Analysis 2.7.3 AOBiome SWOT Analysis 2.7.4 AOBiome Product and Services 2.7.5 AOBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.8 Synlogic 2.8.1 Synlogic Details 2.8.2 Synlogic Major Business and Total Revenue (Financial Highlights) Analysis 2.8.3 Synlogic SWOT Analysis 2.8.4 Synlogic Product and Services 2.8.5 Synlogic Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.9 PureTech 2.9.1 PureTech Details 2.9.2 PureTech Major Business and Total Revenue (Financial Highlights) Analysis 2.9.3 PureTech SWOT Analysis 2.9.4 PureTech Product and Services 2.9.5 PureTech Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.10 Second Genome 2.10.1 Second Genome Details 2.10.2 Second Genome Major Business and Total Revenue (Financial Highlights) Analysis 2.10.3 Second Genome SWOT Analysis 2.10.4 Second Genome Product and Services 2.10.5 Second Genome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.11 Ritter Pharmaceuticals 2.11.1 Ritter Pharmaceuticals Details 2.11.2 Ritter Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis 2.11.3 Ritter Pharmaceuticals SWOT Analysis 2.11.4 Ritter Pharmaceuticals Product and Services 2.11.5 Ritter Pharmaceuticals Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.12 Azitra 2.12.1 Azitra Details 2.12.2 Azitra Major Business and Total Revenue (Financial Highlights) Analysis 2.12.3 Azitra SWOT Analysis 2.12.4 Azitra Product and Services 2.12.5 Azitra Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.13 C3 Jian 2.13.1 C3 Jian Details 2.13.2 C3 Jian Major Business and Total Revenue (Financial Highlights) Analysis 2.13.3 C3 Jian SWOT Analysis 2.13.4 C3 Jian Product and Services 2.13.5 C3 Jian Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.14 Osel 2.14.1 Osel Details 2.14.2 Osel Major Business and Total Revenue (Financial Highlights) Analysis 2.14.3 Osel SWOT Analysis 2.14.4 Osel Product and Services 2.14.5 Osel Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.15 Symberix 2.15.1 Symberix Details 2.15.2 Symberix Major Business and Total Revenue (Financial Highlights) Analysis 2.15.3 Symberix SWOT Analysis 2.15.4 Symberix Product and Services 2.15.5 Symberix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.16 Metabiomics 2.16.1 Metabiomics Details 2.16.2 Metabiomics Major Business and Total Revenue (Financial Highlights) Analysis 2.16.3 Metabiomics SWOT Analysis 2.16.4 Metabiomics Product and Services 2.16.5 Metabiomics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.17 Rebiotix 2.17.1 Rebiotix Details 2.17.2 Rebiotix Major Business and Total Revenue (Financial Highlights) Analysis 2.17.3 Rebiotix SWOT Analysis 2.17.4 Rebiotix Product and Services 2.17.5 Rebiotix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.18 Symbiotix Biotherapies 2.18.1 Symbiotix Biotherapies Details 2.18.2 Symbiotix Biotherapies Major Business and Total Revenue (Financial Highlights) Analysis 2.18.3 Symbiotix Biotherapies SWOT Analysis 2.18.4 Symbiotix Biotherapies Product and Services 2.18.3 Symbiotix Biotherapies Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.19 OpenBiome 2.19.1 OpenBiome Details 2.19.2 OpenBiome Major Business and Total Revenue (Financial Highlights) Analysis 2.19.3 OpenBiome SWOT Analysis 2.19.4 OpenBiome Product and Services 2.19.5 OpenBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.20 MicroBiome Therapeutics LLC 2.20.1 MicroBiome Therapeutics LLC Details 2.20.2 MicroBiome Therapeutics LLC Major Business and Total Revenue (Financial Highlights) Analysis 2.20.3 MicroBiome Therapeutics LLC SWOT Analysis 2.20.4 MicroBiome Therapeutics LLC Product and Services 2.20.5 MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.21 Metabogen 2.21.1 Metabogen Details 2.21.2 Metabogen Major Business and Total Revenue (Financial Highlights) Analysis 2.21.3 Metabogen SWOT Analysis 2.21.4 Metabogen Product and Services 2.21.5 Metabogen Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 3 Market Competition, by Players 3.1 Global Microbiome Therapeutics Revenue and Share by Players (2015-2020) 3.2 Market Concentration Rate 3.2.1 Top 5 Microbiome Therapeutics Players Market Share 3.2.2 Top 10 Microbiome Therapeutics Players Market Share 3.3 Market Competition Trend 4 Market Size by Regions 4.1 Global Microbiome Therapeutics Revenue and Market Share by Regions 4.2 North America Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 4.3 Europe Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 4.4 Asia-Pacific Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 4.5 South America Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 4.6 Middle East & Africa Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 5 North America Microbiome Therapeutics Revenue by Countries 5.1 North America Microbiome Therapeutics Revenue by Countries (2015-2020) 5.2 USA Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 5.3 Canada Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 5.4 Mexico Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 6 Europe Microbiome Therapeutics Revenue by Countries 6.1 Europe Microbiome Therapeutics Revenue by Countries (2015-2020) 6.2 Germany Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 6.3 UK Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 6.4 France Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 6.5 Russia Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 6.6 Italy Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 7 Asia-Pacific Microbiome Therapeutics Revenue by Countries 7.1 Asia-Pacific Microbiome Therapeutics Revenue by Countries (2015-2020) 7.2 China Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 7.3 Japan Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 7.4 Korea Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 7.5 India Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 7.6 Southeast Asia Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 8 South America Microbiome Therapeutics Revenue by Countries 8.1 South America Microbiome Therapeutics Revenue by Countries (2015-2020) 8.2 Brazil Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 8.3 Argentina Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 9 Middle East & Africa Revenue Microbiome Therapeutics by Countries 9.1 Middle East & Africa Microbiome Therapeutics Revenue by Countries (2015-2020) 9.2 Saudi Arabia Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 9.3 UAE Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 9.4 Egypt Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 9.5 South Africa Microbiome Therapeutics Revenue and Growth Rate (2015-2020) 10 Market Size Segment by Type 10.1 Global Microbiome Therapeutics Revenue and Market Share by Type (2015-2020) 10.2 Global Microbiome Therapeutics Market Forecast by Type (2019-2024) 10.3 Upper GIT Revenue Growth Rate (2015-2025) 10.4 Lower GIT Revenue Growth Rate (2015-2025) 11 Global Microbiome Therapeutics Market Segment by Application 11.1 Global Microbiome Therapeutics Revenue Market Share by Application (2015-2020) 11.2 Microbiome Therapeutics Market Forecast by Application (2019-2024) 11.3 Inflammatory Bowel Disease (IBD) Revenue Growth (2015-2020) 11.4 Orphan Drug Revenue Growth (2015-2020) 11.5 Immuno-oncology Revenue Growth (2015-2020) 11.6 Others Revenue Growth (2015-2020) 12 Global Microbiome Therapeutics Market Size Forecast (2021-2025) 12.1 Global Microbiome Therapeutics Market Size Forecast (2021-2025) 12.2 Global Microbiome Therapeutics Market Forecast by Regions (2021-2025) 12.3 North America Microbiome Therapeutics Revenue Market Forecast (2021-2025) 12.4 Europe Microbiome Therapeutics Revenue Market Forecast (2021-2025) 12.5 Asia-Pacific Microbiome Therapeutics Revenue Market Forecast (2021-2025) 12.6 South America Microbiome Therapeutics Revenue Market Forecast (2021-2025) 12.7 Middle East & Africa Microbiome Therapeutics Revenue Market Forecast (2021-2025) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source 14.3 Disclaimer 14.4 About US

List of Tables Table 1. Global Microbiome Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Microbiome Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Microbiome Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Global Market Microbiome Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025 Table 5. Seres Therapeutics Corporate Information, Location and Competitors Table 6. Seres Therapeutics Microbiome Therapeutics Major Business Table 7. Seres Therapeutics Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 8. Seres Therapeutics SWOT Analysis Table 9. Seres Therapeutics Microbiome Therapeutics Product and Solutions Table 10. Seres Therapeutics Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 11. 4D Pharma Corporate Information, Location and Competitors Table 12. 4D Pharma Microbiome Therapeutics Major Business Table 13. 4D Pharma Microbiome Therapeutics Total Revenue (USD Million) (2018-2019) Table 14. 4D Pharma SWOT Analysis Table 15. 4D Pharma Microbiome Therapeutics Product and Solutions Table 16. 4D Pharma Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 17. Interxon Corporate Information, Location and Competitors Table 18. Interxon Microbiome Therapeutics Major Business Table 19. Interxon Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 20. Interxon SWOT Analysis Table 21. Interxon Microbiome Therapeutics Product and Solutions Table 22. Interxon Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 23. Assembly Biosciences Corporate Information, Location and Competitors Table 24. Assembly Biosciences Microbiome Therapeutics Major Business Table 25. Assembly Biosciences Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 26. Assembly Biosciences SWOT Analysis Table 27. Assembly Biosciences Microbiome Therapeutics Product and Solutions Table 28. Assembly Biosciences Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 29. Enterome BioScience Corporate Information, Location and Competitors Table 30. Enterome BioScience Microbiome Therapeutics Major Business Table 31. Enterome BioScience Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 32. Enterome BioScience SWOT Analysis Table 33. Enterome BioScience Microbiome Therapeutics Product and Solutions Table 34. Enterome BioScience Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 35. Synthetic Biologics Corporate Information, Location and Competitors Table 36. Synthetic Biologics Microbiome Therapeutics Major Business Table 37. Synthetic Biologics Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 38. Synthetic Biologics SWOT Analysis Table 39. Synthetic Biologics Microbiome Therapeutics Product and Solutions Table 40. Synthetic Biologics Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 41. AOBiome Corporate Information, Location and Competitors Table 42. AOBiome Microbiome Therapeutics Major Business Table 43. AOBiome Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 44. AOBiome SWOT Analysis Table 45. AOBiome Microbiome Therapeutics Product and Solutions Table 46. AOBiome Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 47. Synlogic Corporate Information, Location and Competitors Table 48. Synlogic Microbiome Therapeutics Major Business Table 49. Synlogic Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 50. Synlogic SWOT Analysis Table 51. Synlogic Microbiome Therapeutics Product and Solutions Table 52. Synlogic Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 53. PureTech Corporate Information, Location and Competitors Table 54. PureTech Microbiome Therapeutics Major Business Table 55. PureTech Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 56. PureTech SWOT Analysis Table 57. PureTech Microbiome Therapeutics Product and Solutions Table 58. PureTech Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 59. Second Genome Corporate Information, Location and Competitors Table 60. Second Genome Microbiome Therapeutics Major Business Table 61. Second Genome Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 62. Second Genome SWOT Analysis Table 63. Second Genome Microbiome Therapeutics Product and Solutions Table 64. Second Genome Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 65. Ritter Pharmaceuticals Corporate Information, Location and Competitors Table 66. Ritter Pharmaceuticals Microbiome Therapeutics Major Business Table 67. Ritter Pharmaceuticals Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 68. Ritter Pharmaceuticals SWOT Analysis Table 69. Ritter Pharmaceuticals Microbiome Therapeutics Product and Solutions Table 70. Ritter Pharmaceuticals Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 71. Azitra Corporate Information, Location and Competitors Table 72. Azitra Microbiome Therapeutics Major Business Table 73. Azitra Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 74. Azitra SWOT Analysis Table 75. Azitra Microbiome Therapeutics Product and Solutions Table 76. Azitra Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 77. C3 Jian Corporate Information, Location and Competitors Table 78. C3 Jian Microbiome Therapeutics Major Business Table 79. C3 Jian Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 80. C3 Jian SWOT Analysis Table 81. C3 Jian Microbiome Therapeutics Product and Solutions Table 82. C3 Jian Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 83. Osel Corporate Information, Location and Competitors Table 84. Osel Microbiome Therapeutics Major Business Table 85. Osel Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 86. Osel SWOT Analysis Table 87. Osel Microbiome Therapeutics Product and Solutions Table 88. Osel Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 89. Symberix Corporate Information, Location and Competitors Table 90. Symberix Microbiome Therapeutics Major Business Table 91. Symberix Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 92. Symberix SWOT Analysis Table 93. Symberix Microbiome Therapeutics Product and Solutions Table 94. Symberix Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 95. Metabiomics Corporate Information, Location and Competitors Table 96. Metabiomics Microbiome Therapeutics Major Business Table 97. Metabiomics Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 98. Metabiomics SWOT Analysis Table 99. Metabiomics Microbiome Therapeutics Product and Solutions Table 100. Metabiomics Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 101. Rebiotix Corporate Information, Location and Competitors Table 102. Rebiotix Microbiome Therapeutics Major Business Table 103. Rebiotix Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 104. Rebiotix SWOT Analysis Table 105. Rebiotix Microbiome Therapeutics Product and Solutions Table 106. Rebiotix Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 107. Symbiotix Biotherapies Microbiome Therapeutics Type and Application Table 108. Symbiotix Biotherapies Microbiome Therapeutics Major Business Table 109. Symbiotix Biotherapies Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 110. Symbiotix Biotherapies SWOT Analysis Table 111. Symbiotix Biotherapies Microbiome Therapeutics Product and Solutions Table 112. Symbiotix Biotherapies Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 113. OpenBiome Corporate Information, Location and Competitors Table 114. OpenBiome Microbiome Therapeutics Major Business Table 115. OpenBiome Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 116. OpenBiome SWOT Analysis Table 117. OpenBiome Microbiome Therapeutics Product and Solutions Table 118. OpenBiome Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 119. MicroBiome Therapeutics LLC Corporate Information, Location and Competitors Table 120. MicroBiome Therapeutics LLC Microbiome Therapeutics Major Business Table 121. MicroBiome Therapeutics LLC Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 122. MicroBiome Therapeutics LLC SWOT Analysis Table 123. MicroBiome Therapeutics LLC Microbiome Therapeutics Product and Solutions Table 124. MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 125. Metabogen Corporate Information, Location and Competitors Table 126. Metabogen Microbiome Therapeutics Major Business Table 127. Metabogen Microbiome Therapeutics Total Revenue (USD Million) (2017-2018) Table 128. Metabogen SWOT Analysis Table 129. Metabogen Microbiome Therapeutics Product and Solutions Table 130. Metabogen Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 131. Global Microbiome Therapeutics Revenue (Million USD) by Players (2015-2020) Table 132. Global Microbiome Therapeutics Revenue Share by Players (2015-2020) Table 133. Global Microbiome Therapeutics Revenue (Million USD) by Regions (2015-2020) Table 134. Global Microbiome Therapeutics Revenue Market Share by Regions (2015-2020) Table 135. North America Microbiome Therapeutics Revenue by Countries (2015-2020) Table 136. North America Microbiome Therapeutics Revenue Market Share by Countries (2015-2020) Table 137. Europe Microbiome Therapeutics Revenue (Million USD) by Countries (2015-2020) Table 138. Asia-Pacific Microbiome Therapeutics Revenue (Million USD) by Countries (2015-2020) Table 139. South America Microbiome Therapeutics Revenue by Countries (2015-2020) Table 140. South America Microbiome Therapeutics Revenue Market Share by Countries (2015-2020) Table 141. Middle East and Africa Microbiome Therapeutics Revenue (Million USD) by Countries (2015-2020) Table 142. Middle East and Africa Microbiome Therapeutics Revenue Market Share by Countries (2015-2020) Table 143. Global Microbiome Therapeutics Revenue (Million USD) by Type (2015-2020) Table 144. Global Microbiome Therapeutics Revenue Share by Type (2015-2020) Table 145. Global Microbiome Therapeutics Revenue Forecast by Type (2021-2025) Table 146. Global Microbiome Therapeutics Revenue by Application (2015-2020) Table 147. Global Microbiome Therapeutics Revenue Share by Application (2015-2020) Table 148. Global Microbiome Therapeutics Revenue Forecast by Application (2021-2025) Table 149. Global Microbiome Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025) List of Figures Figure 1. Microbiome Therapeutics Picture Figure 2. Global Microbiome Therapeutics Revenue Market Share by Type in 2019 Figure 3. Upper GIT Picture Figure 4. Lower GIT Picture Figure 5. Microbiome Therapeutics Revenue Market Share by Application in 2019 Figure 6. Inflammatory Bowel Disease (IBD) Picture Figure 7. Orphan Drug Picture Figure 8. Immuno-oncology Picture Figure 9. Others Picture Figure 10. Global Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2015-2025) Figure 11. North America Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2015-2025) Figure 12. Europe Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2015-2025) Figure 13. Asia-Pacific Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2015-2025) Figure 14. South America Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2015-2025) Figure 15. Middle East and Africa Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2015-2025) Figure 16. Global Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2015-2025) Figure 17. Global Microbiome Therapeutics Revenue Share by Players in 2019 Figure 18. Global Top 5 Players Microbiome Therapeutics Revenue Market Share in 2019 Figure 19. Global Top 10 Players Microbiome Therapeutics Revenue Market Share in 2019 Figure 20. Key Players Market Share Trend Figure 21. Global Microbiome Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020) Figure 22. Global Microbiome Therapeutics Revenue Market Share by Regions (2015-2020) Figure 23. Global Microbiome Therapeutics Revenue Market Share by Regions in 2018 Figure 24. North America Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 25. Europe Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 26. Asia-Pacific Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 27. South America Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 28. Middle East and Africa Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 29. North America Microbiome Therapeutics Revenue Market Share by Countries (2015-2020) Figure 30. North America Microbiome Therapeutics Revenue Market Share by Countries in 2019 Figure 31. USA Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 32. Canada Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 33. Mexico Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 34. Europe Microbiome Therapeutics Revenue Market Share by Countries (2015-2020) Figure 35. Europe Microbiome Therapeutics Revenue Market Share by Countries in 2019 Figure 36. Germany Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 37. UK Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 38. France Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 39. Russia Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 40. Italy Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 41. Asia-Pacific Microbiome Therapeutics Revenue Market Share by Countries (2015-2020) Figure 42. Asia-Pacific Microbiome Therapeutics Revenue Market Share by Countries in 2019 Figure 43. China Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 44. Japan Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 45. Korea Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 46. India Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 47. Southeast Asia Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 48. South America Microbiome Therapeutics Revenue Market Share by Countries (2015-2020) Figure 49. South America Microbiome Therapeutics Revenue Market Share by Countries in 2019 Figure 50. Brazil Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 51. Argentina Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 52. Middle East and Africa Microbiome Therapeutics Revenue Market Share by Countries (2015-2020) Figure 53. Middle East and Africa Microbiome Therapeutics Revenue Market Share by Countries in 2019 Figure 54. Saudi Arabia Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 55. UAE Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 56. Egypt Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 57. South Africa Microbiome Therapeutics Revenue and Growth Rate (2015-2020) Figure 58. Global Microbiome Therapeutics Revenue Share by Type (2015-2020) Figure 59. Global Microbiome Therapeutics Revenue Share by Type in 2019 Figure 60. Global Microbiome Therapeutics Market Share Forecast by Type (2021-2025) Figure 61. Global Upper GIT Revenue Growth Rate (2015-2020) Figure 62. Global Lower GIT Revenue Growth Rate (2015-2020) Figure 63. Global Microbiome Therapeutics Revenue Share by Application (2015-2020) Figure 64. Global Microbiome Therapeutics Revenue Share by Application in 2019 Figure 65. Global Microbiome Therapeutics Market Share Forecast by Application (2021-2025) Figure 66. Global Inflammatory Bowel Disease (IBD) Revenue Growth Rate (2015-2020) Figure 67. Global Orphan Drug Revenue Growth Rate (2015-2020) Figure 68. Global Immuno-oncology Revenue Growth Rate (2015-2020) Figure 69. Global Others Revenue Growth Rate (2015-2020) Figure 70. Global Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025) Figure 71. Global Microbiome Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025) Figure 72. Global Microbiome Therapeutics Revenue Market Share Forecast by Regions (2021-2025) Figure 73. North America Microbiome Therapeutics Revenue Market Forecast (2021-2025) Figure 74. Europe Microbiome Therapeutics Revenue Market Forecast (2021-2025) Figure 75. Asia-Pacific Microbiome Therapeutics Revenue Market Forecast (2021-2025) Figure 76. South America Microbiome Therapeutics Revenue Market Forecast (2021-2025) Figure 77. Middle East and Africa Microbiome Therapeutics Revenue Market Forecast (2021-2025) Figure 78. Sales Channel: Direct Channel vs Indirect Channel